Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MF/F MDI with integrated dose counter in asthma and COPD
NCT00604500Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Mar 2008
- Primary completion
- Nov 2008
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of mometasone furoate + formoterol fumarate in asthma, chronic obstructive pulmonary disease (COPD), sponsored by Organon & Co.. Started Mar 2008; status: completed.
02
Drugs
mometasone furoate + formoterol fumarate
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00604500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00604500.